Target intelligence / Profile preview

Glutaredoxin (Grx)

Target
Grx
Molecular classification
Enzyme, Oxidoreductase, Redox enzyme, Thioredoxin family protein
01

Overview

Glutaredoxin is a small redox enzyme and member of the thioredoxin protein family, present in nearly all organisms from bacteria to humans[1][2][3][4]. It contains a catalytic site typically composed of a cysteine pair (Cys-X-X-Cys motif), enabling it to catalyze the reversible reduction of protein or substrate disulfides using glutathione as a cofactor. Uniquely, glutaredoxins use the glutathione system—specifically, reduced glutathione (GSH) as an electron donor and glutathione reductase for GSH recycling—instead of a dedicated reductase protein[1][3][5]. Their primary roles include maintenance of cellular redox homeostasis, defense against oxidative stress, and regulation of protein function via reversible protein S-glutathionylation and deglutathionylation, crucial in a wide range of physiological and pathological contexts, from DNA synthesis (as hydrogen donor for ribonucleotide reductase) to the assembly and transfer of iron-sulfur clusters important for mitochondrial function[2][3][4]. Glutaredoxins have distinct isoforms (e.g. GLRX1, GLRX2, GLRX3, GLRX5) with specialized functions and localizations in cells[3][7]. Dysregulation or mutation in glutaredoxins has been implicated in cancer, neurodegeneration, cardiovascular conditions, and immune disorders, supporting ongoing interest in the class as putative therapeutic targets and biomarkers[2][3][4].

Other names
ThioltransferaseGrxGlutaredoxin-1 (GLRX1)Glutaredoxin-2 (GLRX2)Glutaredoxin-3 (GLRX3)Glutaredoxin-5 (GLRX5)Thiol-disulfide oxidoreductase
02

Mechanism of action

Catalysis of glutathione-dependent reduction of disulfides and mixed disulfides, regulating cellular redox state and modulating protein function via reversible glutathionylation[2][3].

03

Biological functions

Redox homeostasisAntioxidant defenseReduction of protein disulfides and glutathione-mixed disulfides (glutathionylation/deglutathionylation)Electron donor for ribonucleotide reductaseIron-sulfur cluster binding and traffickingRegulation of apoptosisSignal transduction
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseImmune response/InflammationOxidative stress-related diseases
05

Safety considerations

Targeting glutaredoxins for therapy entails potential disruption of essential redox and antioxidant defenses, risking increased susceptibility to oxidative cell and tissue damage and mitochondrial dysfunction[2][4].
06

Interacting drugs

There are currently no widely approved drugs that directly target glutaredoxin in clinical use; research compounds and inhibitors/activators exist but are primarily used in experimental or preclinical settings[2][3].
07

Biomarkers

Cellular or tissue expression of glutaredoxin isoforms (e.g., GLRX1, GLRX2) may serve as biomarkers of oxidative stress and redox balance in certain diseases, with explored but not widely clinically adopted utility for patient selection or efficacy monitoring[2].

Beyond the preview

Go deeper on Glutaredoxin (Grx).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutaredoxin (Grx).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call